- DCGI says there is no need for experimental testing in India
- Only allowed for vaccines approved in certain countries
- Opportunity for Pfizer and Moderna Vaccines
Bengaluru News: Foreign countries approved by WHO Emergencies in various countries and Covid 19 Drug Controller General of India (DCGI) Said. In the wake of the severe shortage of three vaccines approved in the country Vaccine, It is leading the move in an attempt to sharpen the campaign.
The decision would allow the government to enter India with vaccines such as Pfizer and Moderna, which have appealed to the government to provide immunity without having to carry out a local practice in India and to provide immunity under the laws herein.
Foreign companies that have already been approved by certain countries or healthcare institutions have been granted exemption from the rules for conducting vaccine use before they are approved, and for testing the quality and consistency of vaccines in India. Also, Read This: Vaccine sales are more important to BJP leaders than people’s lives.
“There have been some exceptions due to the drastic increase in the recent Covid 19 cases in India and the need to increase the availability of import vaccines,” DCGI chief VG Somani said.
In the letter, he said the vaccine already approved by the US FDA, EMA, Britain’s MHRA, Japan’s PMDA or WHO Emergency Lists (EUL) list may allow direct emergency use without having to undergo clinical trials in India.
The move was recommended by the National Expert Group on Covid 19 Vaccine Management.